Crossmark

Combination of navitoclax (Bcl-2 and Bcl-xL inhibitor) and Debio-0932 (Hsp90 inhibitor) suppresses the viability of prostate cancer cells via induction of apoptotic signaling pathway

Crossref DOI link: https://doi.org/10.1007/s12032-024-02335-3

Published Online: 2024-03-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

ASDEMİR, Aydemir

ÖZGÜR, Aykut
License Information

Text and Data Mining valid from 2024-03-04

Version of Record valid from 2024-03-04
More Information

Article History

Received: 11 January 2024

Accepted: 19 February 2024

First Online: 4 March 2024

Declarations

:

: Not applicable.

: All authors agree with the publication of this manuscript in this journal.

: The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.

Document is current

Any future updates will be listed below